期刊文献+

Survivin、MMP-2在肾透明细胞癌组织中的表达及关系 被引量:2

Expression of Survivin,MMP-2 in Human Renal Clear Cell Carcinoma
下载PDF
导出
摘要 [目的]探讨Survivin、MMP-2在肾透明细胞癌(renal clear cell carcinoma,RCCC)中的表达及意义。[方法]应用免疫组化技术检测Survivin、MMP-2在55例RCCC和20例正常肾组织中的表达。[结果]从正常肾组织到RCCC组织,Survivin、MMP-2阳性表达量显著升高(P〈0.05)。Survivin的表达与肿瘤大小无明显关系(P〉0.05),与病理分级、临床分期密切相关,G3-G4组、Ⅲ-Ⅳ期组中Survivin的表达明显高于G1-G2组、Ⅰ-Ⅱ期组。MMP-2以肿瘤大小、病理分级、临床分期做分析,两组阳性表达率无明显差异(P〉0.05)。有淋巴结转移患者的Survivin、MMP-2阳性表达量较其对应组增多(P〈0.05)。[结论]Survivin蛋白异常表达在肾透明细胞癌的恶化、侵袭、转移中起重要作用,与RCCC组织细胞生物学特点密切相关,MMP-2在RCCC组织中阳性表达增高。可能在RCCC发生,发展、组织侵袭、转移中起重要作用。Survivin和MMP-2可能成为RCCC的重要诊断指标和治疗靶点。 [Objective]To study the expression and significance of Survivin and MMP-2 in human renal clear cell carcinoma(RCCC).[Methods]Immunohistochemical method was used to detect Survivin and MMP-2 in 55 cases of RCCC and 20 cases of normal kidney.[Results]The positive rate of Survivin expression in RCCC was 65.5%(36/55),higher than in normal renal tissue(0%,0/20)(P〈0.01).There was relationship between Survivin expression and clinical stage and tumor grade of differentiation,but no relationship between Survivin expression and tumor size.The positive rate of MMP-2 expression in RCCC was 61.8%(34/55),higher than in normal renal tissue(25%,5/20)(P〈0.01).There was no relationship between MMP-2 and tumor size,tumor differentiation grade,or clinical stage.There was relationship between Survivin,MMP-2 and lymphonode metastasis(P〈0.05).[Conclusion]Survivin and MMP-2 may play important roles in occurrence and progression of RCCC.Over-expression of survivin and MMP-2 indicates poor prognosis.Survivin and MMP-2 can be important diagnostic/therapeutic targets in RCCC.
出处 《医学临床研究》 CAS 2007年第7期1115-1117,共3页 Journal of Clinical Research
关键词 肾肿瘤/病理学 腺癌 透明细胞/病理学 肿瘤蛋白质类/分析 金属蛋白酶类/分析 kidney neoplasms/PA adenocarcinoma,clear cell/PA neoplasm proteins/AN metalloproteinases/AN
  • 相关文献

参考文献7

  • 1Rodriguez JA,Span SW,Ferreira CG,et al.CRMl-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein surviving[J].Exp Cell Res,2002,275(1):44-53.
  • 2Blanc-Brude OP,Mesri M,Walt NR,et al.Therapeutic targeting of the survivin pathway in cancer:Initiation of mitochondrial apoptosis and suppression of tumor associated angiogenesis[J].Clin Cancer Res,2003,9(7):2683-2692.
  • 3Vagnarelli P,Earnshaw WC.Chromosomal passengers:the four-dimensional regulation of mitosis events[J].Chromosoma,2004,113(5):211-222.
  • 4Tanaka F,Yanagihara K,Otake Y,et al.Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC)[J].Fur J Cardiothorac Surg,2001,19:555-561.
  • 5Parker AS,Kosarik F,Lohse Cmhouston,et al.High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma[J].Cancer,2006,107(1):37-45.
  • 6Adachi Y,Yamamoto H,Itoh F,et al.Clinic pathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal eancers[J].Int J Cancer,2001,95(5):290-294.
  • 7Hemmerlein B,Johanns U,Halbfass J,et al.The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide[J].Int J Oncol,2004;24(5):1069-1076.

同被引文献16

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部